{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:47:28Z","timestamp":1790812048087,"version":"4.1.0"},"reference-count":73,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T00:00:00Z","timestamp":1711497600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPM"],"abstract":"<jats:p>Ovarian cancer (OC) remains a significant health challenge globally, with high mortality rates despite advancements in treatment. Emerging research suggests a potential link between OC development and genital dysbiosis, implicating alterations in the microbiome composition as a contributing factor. To investigate this correlation, a meta-analysis was conducted following PRISMA and MOOSE guidelines, involving eight studies encompassing 3504 patients. Studies investigating the role of upper and inferior genital tract dysbiosis were included, with particular reference to HPV infection and\/or history of pelvic inflammatory disease. The analysis revealed no significant difference in genital dysbiosis prevalence between OC patients and healthy controls. Although previous literature suggests associations between dysbiosis and gynecologic cancers, such as cervical and endometrial cancers, the findings regarding OC are inconclusive. Methodological variations and environmental factors may contribute to these discrepancies, underscoring the need for standardized methodologies and larger-scale studies. Despite the limitations, understanding the microbiome\u2019s role in OC development holds promise for informing preventive and therapeutic strategies. A holistic approach to patient care, incorporating microbiome monitoring and personalized interventions, may offer insights into mitigating OC risk and improving treatment outcomes. Further research with robust methodologies is warranted to elucidate the complex interplay between dysbiosis and OC, potentially paving the way for novel preventive and therapeutic approaches.<\/jats:p>","DOI":"10.3390\/jpm14040351","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T13:39:56Z","timestamp":1711546796000},"page":"351","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Exploring the Relationship between Ovarian Cancer and Genital Microbiota: A Systematic Review and Meta-Analysis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4720-5663","authenticated-orcid":false,"given":"Vito Andrea","family":"Capozzi","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital of Parma, 43125 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1818-0105","authenticated-orcid":false,"given":"Giosu\u00e8 Giordano","family":"Incognito","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Medical Surgical Specialties, University of Catania, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Scarpelli","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital of Parma, 43125 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Palumbo","sequence":"additional","affiliation":[{"name":"Department of General Surgery and Medical Surgical Specialties, University of Catania, 95124 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1243-5357","authenticated-orcid":false,"given":"Cinzia Lucia","family":"Randazzo","sequence":"additional","affiliation":[{"name":"Department of Agricultural, Food and Environment, University of Catania, Santa Sofia Street 100, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8246-106X","authenticated-orcid":false,"given":"Alessandra","family":"Pino","sequence":"additional","affiliation":[{"name":"Department of Agricultural, Food and Environment, University of Catania, Santa Sofia Street 100, 95123 Catania, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6071-0245","authenticated-orcid":false,"given":"Marco","family":"La Verde","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialized Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9023-282X","authenticated-orcid":false,"given":"Carlo","family":"Ronsini","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialized Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3676-7716","authenticated-orcid":false,"given":"Gaetano","family":"Riemma","sequence":"additional","affiliation":[{"name":"Department of Woman, Child and General and Specialized Surgery, University of Campania \u201cLuigi Vanvitelli\u201d, 80138 Naples, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Gaiano","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital of Parma, 43125 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Romeo","sequence":"additional","affiliation":[{"name":"Unit of Gynecology and Obstetrics, Department of Human Pathology of Adult and Childhood \u201cG. Barresi\u201d, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Palmara","sequence":"additional","affiliation":[{"name":"Unit of Gynecology and Obstetrics, Department of Human Pathology of Adult and Childhood \u201cG. Barresi\u201d, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2324-5409","authenticated-orcid":false,"given":"Roberto","family":"Berretta","sequence":"additional","affiliation":[{"name":"Department of Obstetrics and Gynecology, University Hospital of Parma, 43125 Parma, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0548-9891","authenticated-orcid":false,"given":"Stefano","family":"Cianci","sequence":"additional","affiliation":[{"name":"Unit of Gynecology and Obstetrics, Department of Human Pathology of Adult and Childhood \u201cG. Barresi\u201d, University of Messina, 98122 Messina, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,3,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1159\/000479006","article-title":"Ovarian Cancer: A Heterogeneous Disease","volume":"85","author":"Leary","year":"2018","journal-title":"Pathobiology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"m3773","DOI":"10.1136\/bmj.m3773","article-title":"Treatment of epithelial ovarian cancer","volume":"371","author":"Kuroki","year":"2020","journal-title":"BMJ"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1080\/02656736.2018.1503346","article-title":"Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer","volume":"35","author":"Paris","year":"2018","journal-title":"Int. J. Hyperth."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2021.11.012","article-title":"Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial\u2014DRAGON","volume":"164","author":"Cianci","year":"2022","journal-title":"Gynecol. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global Cancer Statistics 2020: GLOBOCANEstimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.annonc.2023.11.015","article-title":"ESGO\u2013ESMO\u2013ESP consensus conference recommendations on ovarian cancer: Pathology and molecular biology and early, advanced and recurrent disease","volume":"35","author":"Ledermann","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/s13048-021-00911-z","article-title":"Investigation on factors associated with ovarian cancer: An umbrella review of systematic review and meta-analyses","volume":"14","author":"Tanha","year":"2021","journal-title":"J. Ovarian Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Furci, F., Cicero, N., Allegra, A., and Gangemi, S. (2023). Microbiota, Diet and Acute Leukaemia: Tips and Tricks on Their Possible Connections. Nutrients, 15.","DOI":"10.3390\/nu15194253"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1224669","DOI":"10.3389\/fonc.2023.1224669","article-title":"The role of microbiota in the development and treatment of gastric cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Front. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"4680","DOI":"10.1073\/pnas.1002611107","article-title":"Vaginal microbiome of reproductive-age women","volume":"108","author":"Ravel","year":"2011","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1146\/annurev-micro-092611-150157","article-title":"Vaginal microbiome: Rethinking health and disease","volume":"66","author":"Ma","year":"2012","journal-title":"Annu. Rev. Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1007\/s00203-021-02414-3","article-title":"Vaginal microbiome: Normalcy vs dysbiosis","volume":"203","author":"Saraf","year":"2021","journal-title":"Arch. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.7150\/jca.20497","article-title":"Linking gut microbiota to colorectal cancer","volume":"8","author":"Raskov","year":"2017","journal-title":"J. Cancer"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.1038\/s41598-021-81931-z","article-title":"A clinical pilot study on the effect of the probiotic Lacticaseibacillus rhamnosus TOM 22.8 strain in women with vaginal dysbiosis","volume":"11","author":"Pino","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nature06244","article-title":"The human microbiome project","volume":"449","author":"Turnbaugh","year":"2007","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e28898","DOI":"10.1002\/jmv.28898","article-title":"Association between vaginal microbiota and the progression of ovarian cancer","volume":"95","author":"Li","year":"2023","journal-title":"J. Med. Virol."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Zhao, X., Liu, Z., and Chen, T. (2023). Potential Role of Vaginal Microbiota in Ovarian Cancer Carcinogenesis, Progression and Treatment. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15030948"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1136\/gutjnl-2019-318556","article-title":"International Cancer Microbiome Consortium consensus statement on the role of the human microbiome in carcinogenesis","volume":"68","author":"Scott","year":"2019","journal-title":"Gut"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J. Clin. Epidemiol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Moher, D., Liberati, A., Tetzlaff, J., Altman, D.G., and PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med., 6.","DOI":"10.1371\/journal.pmed.1000097"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Higgins, J.P.T., Morgan, R.L., Rooney, A.A., Taylor, K.W., Thayer, K.A., Raquel, A., Silva, R.A., Courtney Lemeris, C., Akl, E.A., and Bateson, T.F. (2024). A tool to assess risk of bias in non-randomized follow-up studies of exposure effects (ROBINS-E). Environ. Int., 108602.","DOI":"10.1016\/j.envint.2024.108602"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jrsm.1411","article-title":"Risk-of-bias VISualization (robvis): An R package and Shiny web app for visualizing risk-of-bias assessments","volume":"12","author":"McGuinness","year":"2020","journal-title":"Res. Synth. Methods"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"ref_25","first-page":"89","article-title":"A nonparametric \u201ctrim and fill\u201d method of accounting for publication bias in meta-analysis","volume":"95","author":"Duval","year":"2000","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol. Bull."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat. Med."},{"key":"ref_28","first-page":"1233","article-title":"Lack of HPV in Benign and Malignant Epithelial Ovarian Tumors in Iran","volume":"18","author":"Farzaneh","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1023\/A:1011236803257","article-title":"Prospective study of antibody to human papilloma virus type 16 and risk of cervical, endometrial, and ovarian cancers (United States)","volume":"12","author":"Hisada","year":"2001","journal-title":"Cancer Causes Control"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1002\/ijc.32999","article-title":"Serologic markers of Chlamydia trachomatis and other sexually transmitted infections and subsequent ovarian cancer risk: Results from the EPIC cohort","volume":"147","author":"Idahl","year":"2020","journal-title":"Int. J. Cancer"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tranon.2019.09.007","article-title":"Chlamydia trachomatis and Anti-MUC1 Serology and Subsequent Risk of High-Grade Serous Ovarian Cancer: A Population-Based Case\u2013Control Study in Northern Sweden","volume":"13","author":"Jonsson","year":"2020","journal-title":"Transl. Oncol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1080\/07399330601128627","article-title":"Human papillomavirus infection in malignant and benign gynaecological conditions: A study in Greek women","volume":"28","author":"Konidaris","year":"2007","journal-title":"Health Care Women Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1002\/cncr.11008","article-title":"p53 codon 72 polymorphism (C\/G) and the risk of human papillomavirus-associated carcinomas in China","volume":"95","author":"Li","year":"2002","journal-title":"Cancer"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1086\/368380","article-title":"Serologic evidence of past infection with Chlamydia trachomatis, in relation to ovarian cancer","volume":"187","author":"Ness","year":"2003","journal-title":"J. Infect. Dis."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"219672","DOI":"10.1155\/2008\/219672","article-title":"Chlamydia trachomatis serology in women with and without ovarian cancer","volume":"2008","author":"Ness","year":"2008","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/nm.4517","article-title":"Current understanding of the human microbiome","volume":"24","author":"Gilbert","year":"2018","journal-title":"Nat. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2281360","DOI":"10.1080\/19490976.2023.2281360","article-title":"Gut feelings: The relations between depression, anxiety, psychotropic drugs and the gut microbiome","volume":"15","author":"Brushett","year":"2023","journal-title":"Gut Microbes"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Van Raay, T., and Allen-Vercoe, E. (2017). Microbial Interactions and Interventions in Colorectal Cancer. Microbiol. Spectr., 5.","DOI":"10.1128\/microbiolspec.BAD-0004-2016"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"ftz019","DOI":"10.1093\/femspd\/ftz019","article-title":"Intestinal dysbiosis promotes epithelial-mesenchymal transition by activating tumor-associated macrophages in ovarian cancer","volume":"77","author":"Xu","year":"2019","journal-title":"Pathog. Dis."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/jinfdis\/jiq061","article-title":"Perspective: Alpha-bugs, their microbial partners, and the link to colon cancer","volume":"203","author":"Sears","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"7593","DOI":"10.1038\/s41598-018-25879-7","article-title":"Linking cervicovaginal immune signatures, HPV and microbiota composition in cervical carcinogenesis in non-Hispanic and Hispanic women","volume":"8","author":"Barnes","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"16865","DOI":"10.1038\/srep16865","article-title":"Cervical intraepithelial neoplasia disease progression is associated with increased vaginal microbiome diversity","volume":"5","author":"Mitra","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Audirac-Chalifour, A., Torres-Poveda, K., Bahena-Rom\u00e1n, M., T\u00e9llez-Sosa, J., Mart\u00ednez-Barnetche, J., Cortina-Ceballos, B., L\u00f3pez-Estrada, G., Delgado-Romero, K., Burguete-Garc\u00eda, A.I., and Cant\u00fa, D. (2016). Cervical microbiome and cytokine profile at various stages of cervical cancer: A pilot study. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0153274"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ajog.2018.12.011","article-title":"Vaginal dysbiosis and the risk of human papillomavirus and cervical cancer: Systematic review and meta-analysis","volume":"221","author":"Brusselaers","year":"2018","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/1471-0528.15854","article-title":"The vaginal microbiota, HPV and cervical dysplasia: A systematic review and network meta-analysis","volume":"127","author":"Norenhag","year":"2020","journal-title":"BJOG"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1677\/ERC-10-0053","article-title":"Obesity, inflammatory markers, and endometrial cancer risk: A prospective case-control study","volume":"17","author":"Dossus","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.chom.2016.11.010","article-title":"Prevotella as a hub for vaginal microbiota under the influence of host genetics and their association with obesity","volume":"21","author":"Si","year":"2017","journal-title":"Cell Host Microbe"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s13073-016-0368-y","article-title":"Potential contribution of the uterine microbiome in the development of endometrial cancer","volume":"8","author":"Chen","year":"2016","journal-title":"Genome Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.maturitas.2017.06.025","article-title":"Estrogen\u2013gut microbiome axis: Physiological and clinical implications","volume":"103","author":"Baker","year":"2017","journal-title":"Maturitas"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"80","DOI":"10.15585\/mmwr.mm6603a3","article-title":"Prevalence of Pelvic Inflammatory Disease in Sexually Experienced Women of Reproductive Age\u2014United States, 2013\u20132014","volume":"66","author":"Kreisel","year":"2017","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1093\/infdis\/jiab067","article-title":"Etiology and Diagnosis of Pelvic Inflammatory Disease: Looking Beyond Gonorrhea and Chlamydia","volume":"224","author":"Mitchell","year":"2021","journal-title":"J. Infect. Dis."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"959816","DOI":"10.1155\/2011\/959816","article-title":"Mycoplasma genitalium: An emerging cause of pelvic inflammatory disease","volume":"2011","author":"Haggerty","year":"2011","journal-title":"Infect. Dis. Obstet. Gynecol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/aji.12264","article-title":"Bacterial vaginosis and the cervicovaginal immune response","volume":"71","author":"Mitchell","year":"2014","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1007\/s10096-012-1570-5","article-title":"Viral and bacterial aetiologies of epithelial ovarian cancer","volume":"31","author":"Shanmughapriya","year":"2012","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"The origin and pathogenesis of epithelial ovarian cancer: A proposed unifying theory","volume":"34","author":"Kurman","year":"2010","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/jnci\/91.17.1459","article-title":"Possible role of ovarian epithelial inflammation in ovarian cancer","volume":"91","author":"Ness","year":"1999","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: An ancient link with novel potentials","volume":"121","author":"Hussain","year":"2007","journal-title":"Int. J. Cancer"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1126\/science.aaa4972","article-title":"Cancer and the microbiota","volume":"348","author":"Garrett","year":"2015","journal-title":"Science"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/S1470-2045(11)70165-6","article-title":"Risk of ovarian cancer in women with pelvic inflammatory disease: A population-based study","volume":"12","author":"Lin","year":"2011","journal-title":"Lancet Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1007\/s10552-013-0216-y","article-title":"Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors","volume":"24","author":"Rasmussen","year":"2013","journal-title":"Cancer Causes Control"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.ygyno.2008.07.045","article-title":"Natural history and epidemiology of HPV infection and cervical cancer","volume":"110","year":"2008","journal-title":"Gynecol. Oncol."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Har\u0119\u017ca, D.A., Wilczy\u0144ski, J.R., and Paradowska, E. (2022). Human Papillomaviruses as Infectious Agents in Gynecological Cancers. Oncogenic Properties of Viral Proteins. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031818"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: Signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"319","DOI":"10.4143\/crt.2005.37.6.319","article-title":"The role of HPV E6 and E7 oncoproteins in HPV-associated cervical carcinogenesis","volume":"37","author":"Yim","year":"2005","journal-title":"Cancer Res. Treat."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2217\/fvl.10.73","article-title":"HPV-DNA integration and carcinogenesis: Putative roles for inflammation and oxidative stress","volume":"6","author":"Williams","year":"2011","journal-title":"Futur. Virol."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Cazzaniga, M., Cardinali, M., Di Pierro, F., and Bertuccioli, A. (2022). Ovarian Microbiota, Ovarian Cancer and the Underestimated Role of HPV. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232416019"},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Nakamura, M., Obata, T., Daikoku, T., and Fujiwara, H. (2019). The Association and Significance of p53 in Gynecologic Cancers: The Potential of Targeted Therapy. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20215482"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1097\/IGC.0b013e318280f3e0","article-title":"The prevalence of human papillomavirus in ovarian cancer: A systematic review","volume":"23","author":"Rosa","year":"2013","journal-title":"Int. J. Gynecol. Cancer"},{"key":"ref_69","doi-asserted-by":"crossref","unstructured":"Ntuli, L., Mtshali, A., Mzobe, G., Liebenberg, L.J., and Ngcapu, S. (2022). Role of Immunity and Vaginal Microbiome in Clearance and Persistence of Human Papillomavirus Infection. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.927131"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12934-020-01464-4","article-title":"Vaginal microbiota and the potential of Lactobacillus derivatives in maintaining vaginal health","volume":"19","author":"Chee","year":"2020","journal-title":"Microb. Cell Factories"},{"key":"ref_71","first-page":"621","article-title":"Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: Results of a preliminary, uncontrolled, open trial","volume":"73","author":"Criscuolo","year":"2021","journal-title":"Minerva Obstet. Gynecol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/s41598-023-27555-x","article-title":"Diagnostic and prognostic potential of the microbiome in ovarian cancer treatment response","volume":"13","author":"Asangba","year":"2023","journal-title":"Sci. Rep."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Yu, B., McCartney, S., Strenk, S., Valint, D., Liu, C., Haggerty, C., and Fredricks, D.N. (2023). Vaginal bacteria elicit acute inflammatory response in fallopian tube organoids: A model for pelvic inflammatory disease. Res. Sq., preprint.","DOI":"10.21203\/rs.3.rs-2891189\/v1"}],"container-title":["Journal of Personalized Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/4\/351\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T14:19:19Z","timestamp":1760105959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4426\/14\/4\/351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,27]]},"references-count":73,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4]]}},"alternative-id":["jpm14040351"],"URL":"https:\/\/doi.org\/10.3390\/jpm14040351","relation":{},"ISSN":["2075-4426"],"issn-type":[{"value":"2075-4426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,27]]}}}